Department of Orthopaedics and Traumatology, Hacettepe University, School of Medicine, Ankara, Turkey.
Department of Orthopaedics, University of Missouri-Kansas City, Missouri, USA.
Acta Orthop Traumatol Turc. 2021 Jan;55(1):53-56. doi: 10.5152/j.aott.2021.20019.
The aims of this study were (1) to investigate the changes in the serum concentration of prophylactically administrated vancomycin in the perioperative period of revision hip arthroplasty in penicillin/cephalosporin-allergic patients, (2) to assess whether the postoperative re-administration of vancomycin is needed, and (3) to determine the relationships of vancomycin serum concentration with blood loss, body weight, and fluid replacement in such patients.
This study consisted of 29 patients (20 females, 9 males; mean age=63.3 years; age range=45-79 years) with a history of penicillin/cephalosporin allergy undergoing revision hip arthroplasty secondary to aseptic loosening or periprosthetic fractures. Serum vancomycin levels were measured (1) before administration of vancomycin, (2) at the time of skin incision, (3) every 1,5 hours thereafter until the end of the operation, (4) during the skin closure, and (5) after three and 12 hours from the initial dosage. Data regarding body weight, amounts of intraoperative blood loss, fluid and blood replacements and postoperative wound drainage were recorded.
The average blood loss, fluid replacement, and drain volume were 1280.3±575.8 (500-2700) mL, 2922.6±768.8 (1700-4600) mL, and 480.2±163.7 (200-850) mL, respectively. The mean levels of serum vancomycin were 46.3±21.8 (14.1-80.7) mg/L at the time of skin incision, 17.9±4.7 (9.4-30.9) and 9.8±2.2 (4.3-13.8) mg/L after 1.5 and 3 hours from the beginning of the surgery and 5.1±1.1 (2.9-6.8)mg/L after 12th hour postoperatively. The measured vancomycin levels were below the effective serum concentrations (< 5 mg/L) for 18 patients at 12 hours the administration of the first dose. A moderate level negative correlation between the blood loss/body weight ratio and vancomycin levels was found (p=0.004, r=-0.493). Predictive ROC curve analysis resulted in determining a blood loss volume higher than 1150 ml and a blood loss/body weight ratio higher than 18,5 is significant to estimate the vancomycin level below the minimum effective serum level at 12th hour postoperatively (AUC=0.793±0.16, p=0.009, AUC=0.753) 26±0.12, p=0.025, respectively).
Evidence from this study has indicated vancomycin concentration at 12th hour is below the effective level in most patients. Thus, earlier repetitive infusion of vancomycin seems to be necessary in penicillin/cephalosporin-allergic patients undergoing revision hip arthroplasty, especially in those with high blood loss.
Level III, Therapeutic Study.
本研究旨在(1)探讨青霉素/头孢菌素过敏的髋关节翻修术患者围手术期预防性万古霉素血清浓度的变化,(2)评估术后是否需要重新给予万古霉素,(3)确定万古霉素血清浓度与此类患者的失血量、体重和液体替代之间的关系。
本研究纳入了 29 名(20 名女性,9 名男性;平均年龄=63.3 岁;年龄范围 45-79 岁)因无菌性松动或假体周围骨折而接受髋关节翻修术的青霉素/头孢菌素过敏史患者。测量了万古霉素血清水平(1)在给予万古霉素之前,(2)在皮肤切开时,(3)此后每 1.5 小时直至手术结束,(4)在皮肤关闭时,(5)在初始剂量后 3 小时和 12 小时。记录了体重、术中失血量、液体和血液替代物以及术后伤口引流的数据。
平均失血量、液体替代量和引流量分别为 1280.3±575.8(500-2700)mL、2922.6±768.8(1700-4600)mL 和 480.2±163.7(200-850)mL。万古霉素血清水平在皮肤切开时为 46.3±21.8(14.1-80.7)mg/L,术后 1.5 和 3 小时分别为 17.9±4.7(9.4-30.9)和 9.8±2.2(4.3-13.8)mg/L,术后 12 小时为 5.1±1.1(2.9-6.8)mg/L。18 名患者在首次给药 12 小时时测得的万古霉素水平低于有效血清浓度(<5mg/L)。发现失血量/体重比值与万古霉素水平呈中度负相关(p=0.004,r=-0.493)。预测 ROC 曲线分析得出,失血量大于 1150ml 和失血量/体重比值大于 18.5 可显著预测术后 12 小时万古霉素水平低于最低有效血清水平(AUC=0.793±0.16,p=0.009,AUC=0.753)。26±0.12,p=0.025)。
本研究表明,大多数患者在 12 小时时的万古霉素浓度低于有效水平。因此,在接受髋关节翻修术的青霉素/头孢菌素过敏患者中,似乎需要早期重复给予万古霉素,尤其是在失血量较高的患者中。
III 级,治疗性研究。